Common Equity: The sum of all common equity items.
Ono Pharmaceutical Co. (OPHLF) had Common Equity of $5.20B for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
$3.21B |
|
$330.31M |
|
$976.47M |
|
$2.24B |
|
$2.82B |
|
$394.34M |
|
$-2.77M |
|
$391.56M |
|
$391.56M |
|
$331.09M |
|
$331.09M |
|
$331.10M |
|
$331.09M |
|
$394.34M |
|
$571.84M |
|
469.69M |
|
469.69M |
|
$0.70 |
|
$0.70 |
|
| Balance Sheet Financials | |
$3.00B |
|
$697.76M |
|
$4.02B |
|
$7.02B |
|
$978.75M |
|
$693.00M |
|
$841.81M |
|
$1.82B |
|
|
Common Equity |
$5.20B |
$2.88B |
|
$5.20B |
|
469.77M |
|
| Cash Flow Statement Financials | |
$544.23M |
|
$-902.78M |
|
$622.37M |
|
$1.10B |
|
$1.35B |
|
$253.61M |
|
-- |
|
$-247.68M |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.07 |
|
-- |
|
-- |
|
0.12 |
|
0.17 |
|
69.61% |
|
12.27% |
|
12.27% |
|
17.80% |
|
12.19% |
|
10.28% |
|
$508.44M |
|
-- |
|
-- |
|
-- |
|
0.46 |
|
1.98 |
|
3.61 |
|
101.22 |
|
6.36% |
|
11.48% |
|
4.71% |
|
5.62% |
|
$11.07 |
|
$1.08 |
|
$1.16 |
|